Abstract: Oligonol is a low-molecular-weight polyphenol derived from lychee fruit. This study was conducted to examine whether oligonol has an ameliorative effect on diabetes-induced pancreatic damage via oxidative stress-induced inflammation. Oligonol was orally administered at 10 or 20 mg/kg body weight/day for 10 days to streptozotocin-induced diabetic rats, and changes in serum glucose, C-peptide, insulin, reactive oxygen species (ROS), and thiobarbituric acid-reactive substance (TBARS) levels as well as body weight and food and water consumption were assessed.
Introduction
Glucose is the primary fuel and regulator of pancreatic islet β-cell function. The primary function of insulin is to maintain blood glucose levels in the normal range. However, this homeostatic relationship is disrupted when glucose remains at supraphysiologic levels for protracted periods of time, an event referred to as glucose toxicity [1] [2] [3] . Diabetes, one of the most recognizable endocrine metabolic disorders, is fundamentally characterized by hyperglycemia.
[9] successfully converted the high-molecular-weight proanthocyanidin into the low-molecular-weight proanthocyanidin, which is utilizable in the food industry. Oligonol, which is now available commercially as a novel dietary ingredient, is an optimized phenolic product derived from lychee fruit polyphenols that contain catechin-type monomers and low-molecular-weight oligomers [7] . Kundu et al. [10] reported the beneficial antioxidant and anti-inflammatory effects of oligonol in mouse skin, while Ahn et al. [11] showed that oligonol protects against oxidative stress-induced inflammation in C6 glial cells. In our previous studies, oligonol improved hyperglycemia and hyperglycemia-induced oxidative stress in the liver and kidney of type 2 diabetic db/db mice, attenuated renal damage through the inhibition of glycation end product formation by glucose accumulation, and subsequently decreased NAD(P)H oxidase-derived ROS production in the kidney of db/db mice [12] [13] [14] . Therefore, oligonol appears to represent a novel therapeutic approach to a range of conditions associated with diabetes and hyperglycemia-related disorders such as oxidative stress and inflammation; however, the details of the mechanisms are still unknown.
In the present study, we therefore investigated the mechanisms underlying the protective action of oligonol in pancreatic oxidative damage caused by streptozotocin (STZ)-induced diabetes in a rat model.
Results

Body Weight, Food Intake, Water Intake, and Pancreatic Weight
During the 10 days of the experimental period, diabetic control rats showed a significantly lower body weight gain than the nondiabetic rats did, and the oral administration of 20 mg/kg oligonol to diabetic rats showed a tendency to increase body weight. The diabetic control rats showed an increased food and water intake compared with that reported for the nondiabetic rats.
There was, however, no significant reduction in these parameters following the administration of oligonol. The pancreatic weight of diabetic control rats was 1.91 times higher than that of nondiabetic rats but decreased significantly in the rats administered oligonol, as shown in Figure 1 .
Hematological Analyses
As shown in Figure 2 , diabetic control rats maintained a level of about 410 mg/dL, while nondiabetic rats showed a level of around 130 mg/dL; however, oligonol-administered groups showed a dose-dependent decrease in this level. Furthermore, diabetic control rats showed a marked decrease in serum C-peptide and insulin levels, but oral administration of oligonol at 10 or 20 mg/kg suppressed these decreased levels. The serum levels of ROS and TBARS in diabetic rats orally administered 10 or 20 mg/kg body weight of oligonol decreased in a dose-dependent manner (Table 1) .
Pancreatic Insulin Content
As shown in Figure 3 , the pancreatic insulin content of vehicle-treated diabetic rats significantly decreased compared with that of nondiabetic rats. Oligonol administration at doses of 10 and 20 mg/kg led to a significant increase in the level of insulin.
Biomarkers Associated with Oxidative Stress in the Pancreas
The pancreatic levels of ROS and TBARS in diabetic rats were higher than those of nondiabetic rats, whereas these enhanced levels were significantly reduced by oligonol treatment, almost to the levels of nondiabetic control rats, as shown in Table 1 .
Pancreatic p-p38 and p-ERK1/2 Protein Expressions
In the diabetic control rats, pancreatic p-p38 and p-ERK1/2 protein expressions were significantly higher those in nondiabetic rats (Figure 4) . However, oligonol administration reduced pancreatic p-p38 and p-ERK expressions in diabetic rats.
Pancreatic p-IκBα and NF-κBp65 Protein Expressions
As shown in Figure 5 , pancreatic p-IκBα and NF-κBp65 protein expressions were significantly elevated in diabetic control rats compared with those in nondiabetic rats. These increases in protein expressions in the pancreas of diabetic rats were significantly attenuated in a dose-dependent manner by oligonol administration.
Pancreatic Inflammatory Protein Expressions
The pancreatic expressions of inflammatory proteins COX-2, iNOS, TNF-α, and IL-6 were enhanced in diabetic control rats; however, these increases in expressions were significantly attenuated following oligonol administration ( Figure 6 ). Figure 7 shows the results of histological examination using HE staining to detect pancreatic cell damage. The level of cellular damage was higher in the pancreas of diabetic control rats than in those of nondiabetic rats. These histopathological studies demonstrated that the administration of oligonol had a significant, protective effect against pancreatic cell damage.
Pancreatic Histological Examination
Discussion
Oxidative stress secondary to hyperglycemia is thought to be a major risk factor in the onset and progression of diabetes. Moreover, insulin resistance and β-cell dysfunction may play an important role in the unbalanced redox equation [15] . The antioxidant defense system consists of endogenous antioxidant enzymes such as glutathione peroxidase, superoxide dismutase, and catalase, and exogenous antioxidants obtained mainly by dietary intake such as vitamin C, vitamin E, carotenoids, and polyphenols [16] [17] [18] [19] . Various polyphenols show antioxidant activity because of their free radical scavenging properties and because they are chelators of metal ions; thus, they may protect tissues against free oxygen radicals and lipid peroxidation [20] .
The beneficial effects of oligonol in diabetes have been reported; however, its underlying mechanism has not been elucidated thus far. In this study, to examine the regulatory mechanism of oxidative stress and the oxidative stress-associated inflammatory response of oligonol in hyperglycemia, we focused on the effects of oligonol against pancreatic damage and insulin secretion linked to inflammation using an STZ-induced diabetic rat model.
Our results show that oligonol administration significantly ameliorates adverse metabolic effects in STZ-induced diabetic rats. Significant body weight loss was observed in STZ-induced diabetic rats in comparison with that in nondiabetic rats, whereas body weight following the oral administration of 20 mg oligonol was greater than in diabetic control rats. These results suggest that oligonol may normalize energy metabolism in body tissues. The stimulation of glucose utilization by insulin is one of the major mechanisms for regulation of serum glucose concentrations.
Administering oligonol to diabetic rats significantly improved insulin levels and serum C-peptide, 8 an indirect biomarker of insulin secretion. Therefore, the capability of oligonol to significantly reduce serum glucose levels in diabetic rats may be due to the potentiation of insulin secretion from existing β-cell islets, which subsequently increases the utilization of glucose in tissue.
In the diabetic state, potentially damaging oxidative stress is induced in islets as well as in other cells [21] [22] [23] . Because the expression levels of antioxidant enzymes such as superoxide dismutase, catalase, and glutathione peroxidase are known to be very low in islets compared with Therefore, NF-κB and its target genes might be involved in the regulation of insulin secretion and insulin resistance. In addition, NF-κB activation pathways are thought to be mediated by two distinct redox-related mechanisms: 1) phosphorylation of p38 MAPK, ERK, and c-Jun-NH2-terminal kinase; and 2) enhancement of IκB kinase-dependent IκB degradation [37, 38] .
In the present study, the administration of oligonol to diabetic rats significantly reduced the renal protein expressions of NF-κB and NF-κB-related proinflammatory mediates (COX-2 and iNOS) and cytokines (TNF-α and IL-6). Oligonol was found to block this ROS-dependent activation of the MAPK pathway in the pancreas of diabetic rats. Moreover, oligonol administration resolved the p-IκB levels elevated in the diabetes model, and also decreased the nuclear translocation of NF-κB and NF-κB-related protein expressions. These results suggest that oligonol can modulate diabetic pancreatic inflammation by regulating the MAPK-mediated NF-κB signaling pathway. Furthermore, oligonol led to a reduction in pancreatic tissue inflammation based on histological evaluation. This study focused on the effects of insulin secretion linked to inflammation in the pancreas of diabetic rats treated with oligonol. Our findings show that the administration of oligonol to diabetic rats had a favorable influence on the prevention of pancreatic damage progression, at least in part, by ameliorating hyperglycemia-related MAPK/NF-κB pathway-induced inflammation.
Given that oligonol inhibited oxidative stress-induced MAPK/NF-κB activation-related inflammatory gene expression in the pancreas, these findings provide therapeutic evidence for the beneficial effects of oligonol on ameliorating the development of diabetes-related pancreatic damage.
Materials and Methods
Oligonol
Oligonol obtained from lychee fruit (Litchi chinensis Sonn.) using a patented process (international patent WO 2004/103988 AI) [39] was provided by Amino Up Chemical, Co., Ltd (Sapporo, Japan). The composition of the product is shown in Table 2 . Briefly, the extraction process included the combination of lychee fruit extract (750 g) and green tea extract (150 g) (purchased from Guilin Layn Natural Ingredients, Corp., Guilin, China) with citric acid (150 g) in water (7.5 L). The mixture was heated at 60°C for 16 h. After the solution was cooled to room temperature, it was filtered through a DIAION HP-20 column. The column was washed with water and eluted with 40% (vol/vol) ethanol (80 L). Removal of the solvent from the eluate yielded a reddish-brown powder (674 g) [40] .
Materials
Protease inhibitor mixture solution, 4,6-dihydroxy-2-mercaptopyrimidine (2-thiobarbituric acid), and 10% neutral-buffered formalin were purchased from Wako Pure Chemical Industries, Ltd.
(Osaka, Japan). 2',7'-Dichlorofluorescein diacetate (DCFH-DA) was purchased from Molecular Probes (Eugene, OR, USA). Pure nitrocellulose membrane was purchased from Bio-Rad Laboratories (Tokyo, Japan). Phenylmethylsulfonyl fluoride (PMSF) was purchased from Sigma Chemical Co. (St. Louis, MO, USA). Rabbit polyclonal antibodies against insulin, phosphor (p)-p38, p-extracellular-signal regulated kinase 1/2 (p-ERK1/2), p-inhibitor of nuclear factor-kappa Bα (p-IκBα) and nuclear factor-kappa B (NF-κB)p65, and mouse monoclonal antibodies against cyclooxygenase-2 (COX-2), inducible nitric oxide (NO) synthase (iNOS), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), β-actin, and histone were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Goat anti-rabbit and goat anti-mouse IgG horseradish peroxidase (HRP)-conjugated secondary antibodies were purchased from Santa Cruz Biotechnology, Inc. ECL Western Blotting Detection Reagents were purchased from GE Healthcare (Piscataway, NJ, USA).
All other chemicals and reagents were purchased from Sigma Chemical Co.
Experimental Design
The Guidelines for Animal Experimentation approved by Daegu Haany University (permission No. 2013-036) were followed in the present study. Six-week-old male Sprague-Dawley rats were obtained from Daehan-Bio (Chungcheong, Korea) and were housed with room temperature and humidity maintained automatically at about 25°C and 55%, respectively. All rats were allowed free access to laboratory pellet chow (CLEA Japan, Inc., Tokyo, Japan; comprising 24.0% protein, 3.5% lipids, and 60.5% carbohydrates) and water. After several days of adaptation, the rats were injected intraperitoneally with STZ (50 mg/kg body weight) in 10 mM citrate buffer (pH 4.5). The blood glucose level was determined and body weight was measured 10 days after the injection. To avoid any intergroup differences in these indices, the rats were divided into three experimental groups: group 1, diabetic rats receiving water (n=5); groups 2 and 3, diabetic rats receiving 10 or 20 mg/kg body weight/day of oligonol (n=5, each group) through once-daily oral gavage. The administration dose and duration were determined based on other reports [12] [13] [14] . Rats that underwent a sham injection of citrate buffer without STZ were used as a nondiabetic control group (n=5). After 10 days of treatment, blood samples were obtained from the abdominal aorta under pentobarbital anesthesia (50 mg/kg body weight, intraperitoneally), and serum was prepared by centrifugation. Subsequently, each rat was perfused with ice-cold physiological saline and the pancreas was harvested, snap-frozen in liquid nitrogen, and stored at −80°C until analysis.
Estimation of Serum Parameters
Serum glucose was determined using a commercial kit (Glucose CII-Test; Wako Pure Chemical Industries, Ltd.). Serum C-peptide (Shibayagi Co., Ltd., Gunma, Japan) and insulin (Morinaga Institute of Biological Science, Yokohama, Japan) levels were estimated based on enzyme-linked immunosorbent assays. Serum ROS levels were determined according to the method of Ali et al. [41] , and thiobarbituric acid-reactive substance (TBARS) levels were determined according to the method of Naito and Yamanaka [42] .
Measurement of Insulin Content in the Pancreas
The insulin content of pancreatic tissue was estimated using the method of Portha et al. [43] .
In brief, the pancreas was homogenized for 1 min by ultrasonic disintegration at 4°C in acid-alcohol solution (75% ethanol, 1.5% v/v 12 mol/L HCl, 23.5% distilled water) and the homogenate was maintained at −20°C overnight. Next, the extract was centrifuged and the insulin concentration of the supernatant was estimated by immunosorbent assay.
Determination of ROS Generation and TBARS Level in the Pancreas
ROS generation was measured as described previously [41] . Pancreatic tissues were homogenized on ice with 1 mM EDTA-50 mM sodium phosphate buffer (pH 7.4) and 25 mM DCFH-DA was added to the homogenates. After incubation for 30 min, changes in fluorescence values were determined at an excitation wavelength of 486 nm and emission wavelength of 530 nm.
The pancreatic TBARS level was determined according to the method of Uchiyama and Mihara [44] .
Preparation of Nuclear and Post-Nuclear Fractions
Nuclear protein extraction was carried out as described previously [45] . Briefly, pancreatic tissue was homogenized with ice-cold lysis buffer containing 5 mM Tris-HCl (pH 7.5), 2 mM glycerol, 1 mM PMSF, and protease inhibitor mixture solution. The homogenate was centrifuged at 2,000 × g for 10 min at 4°C. The protein concentration in each fraction was determined using a Pierce BCA protein assay kit (Thermo Scientific, Rockford, IL, USA).
Immunoblotting Analyses
For the estimation of NF-κBp65 and histone protein expression, 10 μg of protein from each nuclear fraction was electrophoresed through a 10% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE). Separated proteins were transferred to a nitrocellulose membrane, blocked with 5% (w/v) skim milk solution for 1 h, and incubated overnight with primary antibodies to NF-κBp65 or histone 4°C. After washing, blots were incubated with anti-rabbit or anti-mouse IgG HRP-conjugated secondary antibody for 1.5 h at room temperature. Next, the protein expression of insulin, p-p38, p-ERK1/2, p-IκBα, COX-2, iNOS, TNF-α, IL-6, and β-actin was determined in 10 μg of protein from each post-nuclear fraction, electrophoresed through 8-15% SDS-PAGE. Each antigen-antibody complex was visualized using ECL Western Blotting Detection Reagents and detected by chemiluminescence with a Sensi-Q2000 Chemidoc system (Lugen Sci Co., Ltd., Seoul, Korea). Band densities were measured using ATTO densitograph software (ATTO Corporation, Tokyo, Japan) and quantified as the ratio to histone and/or β-actin. The protein levels of groups are expressed relative to those of nondiabetic rats (represented as 1).
Histological Examination
Excised sections of pancreatic tissue were fixed immediately in 10% neutral-buffered formalin and embedded in paraffin. Paraffin sections were cut and stained with hematoxylin-eosin (HE) prior to optical microscopy examination. The sections were viewed and photographed using a 
Statistical Analysis
The data are expressed as means ± SEM. Significance was assessed by one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison test using SPSS 11.5.1 software for Windows 2002 (SPSS Inc., USA). Values of p<0.05 were considered significant.
Conclusions
Diabetic rats show decreased insulin secretion through pancreatic damage associated with the expressions of the oxidative stress-induced MAPK activation-derived proinflammatory signaling pathway (IκB/NF-κB pathway) and proinflammatory genes (COX-2, iNOS, TNF-α, and IL-6).
These unfavorable outcomes were reversed by oligonol administration, which improved overall pancreatic β-cell function-related indices, such as serum C-peptide and insulin secretion, pancreatic insulin expression level, and morphological characteristics in diabetic rats (Figure 8 ). 
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